Neurological & Cognitive
Adamax
Scientific Profile
Adamax is a modified derivative of semax, a synthetic heptapeptide analog of ACTH(4-7). Research indicates that Adamax demonstrates enhanced stability and neuroprotective properties compared to its parent compound.
In animal models, Adamax has been shown to modulate BDNF expression and exhibit significant nootropic effects through its interaction with dopaminergic and glutamatergic systems. The compound demonstrates high resistance to enzymatic degradation due to its N-terminal modifications.
This compendium provides objective scientific information on research peptides based solely on published literature. All descriptions are limited to biochemical properties and mechanisms observed in in-vitro or animal studies, with no implications regarding human efficacy or therapeutic applications.